Oncology
Symposium
Resistance to therapy in lung cancer
Clinical
Aims : To describe the main mechanisms of resistance to the drugs that are currently being used to treat lung cancer, present the theoretical strategies to overcome resistance and new drug developments and discuss the clinical implications of drug resistance along with recommendations for planning therapy.
10:45
Resistance to chemotherapy in lung cancer
T. Berghmans(Bruxelles, Belgium)
COI
1
3461
11:20
Mechanisms of EGFR-TKI resistance and new treatment strategies
N. Girard(Paris, France)
COI
2
3462
11:55
The clinical point of view: strategies for overcoming resistance in lung cancer treatment
R. Huber(Munich, Germany)
COI
3
3464
12:30
Panel discussion
4
3463
. . .